Guo, S., Tal, R., Jiang, H., Yuan, T., & Liu, Y
The development of GLP-1 receptor agonists for type 2 diabetes was contextualised within the broader research landscape, including orally bioavailable agonists, allosteric modulators, and unimolecular multi-agonists all of which use the native GLP-1 receptor as their primary target
Known GLP-1 side effects include: nausea, vomiting, diarrhea, dizziness, increased heart rate, infections, headaches, indigestion, pancreatitis, medullary thyroid cancer, sudden kidney injury, worsening diabetic-related retinopathy, shortness of breath, wheezing, hives, difficulty swallowing, rash, abdominal pain and feelings of doom or dread
When omega-3 capsules are consumed alongside a meal containing fat, the gallbladder releases bile acids that emulsify the fatty acids, facilitating their incorporation into mixed micelles
A new study found that females using GLP-1 drugs had about a 30% lower risk of developing breast cancer